{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:21:58Z","timestamp":1794255718137,"version":"4.9.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,5]],"date-time":"2027-10-05T00:00:00Z","timestamp":1822694400000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017559","name":"Recordati Rare Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["R01 FD003720"],"award-info":[{"award-number":["R01 FD003720"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007137","name":"Helse Nord RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U54 DK083909"],"award-info":[{"award-number":["U54 DK083909"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009259","name":"Institute for Translational Sciences, University of Texas Medical Branch","doi-asserted-by":"publisher","award":["UL1 TR001439"],"award-info":[{"award-number":["UL1 TR001439"]}],"id":[{"id":"10.13039\/100009259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ymgme.2026.110263","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:31:19Z","timestamp":1789774279000},"page":"110263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["C-type lectin 10A [CD301] mRNA is upregulated in symptomatic acute intermittent porphyria and decreases after heme treatment"],"prefix":"10.1016","volume":"149","author":[{"given":"Elin","family":"Storjord","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"Bonkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Murti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Toll\u00e5li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshata","family":"Moghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5se","family":"Emblem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole-Lars","family":"Brekke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e5rd Ove","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110263_bb0005","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2026.110263_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020675","article-title":"Acute intermittent porphyria: an overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators","volume":"22","author":"Bustad","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110263_bb0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ymgme.2016.08.006","article-title":"Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: a qualitative study","volume":"119","author":"Naik","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110263_bb0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2018.12.006","article-title":"Lifestyle factors including diet and biochemical biomarkers in acute intermittent porphyria: results from a case-control study in northern Norway","volume":"128","author":"Storjord","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110263_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-med-042921-123602","article-title":"Update on the porphyrias","volume":"75","author":"Dickey","year":"2024","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymgme.2026.110263_bb0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/joim.13463","article-title":"Risk of primary liver cancer in acute hepatic porphyria patients: a matched cohort study of 1244 individuals","volume":"291","author":"Lissing","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2026.110263_bb0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jimd.12583","article-title":"Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: a matched cohort study in 1244 individuals","volume":"46","author":"Lissing","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110263_bb0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/lt.25959","article-title":"Liver transplantation for acute intermittent porphyria","volume":"27","author":"Lissing","year":"2021","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymgme.2026.110263_bb0045","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/clinchem\/48.11.1891","article-title":"Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families","volume":"48","author":"Kauppinen","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2026.110263_bb0050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jimd.12612","article-title":"Key terms and definitions in acute porphyrias: results of an international Delphi consensus led by the European porphyria network","volume":"46","author":"Stein","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110263_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70156","article-title":"A prospective, blinded study of symptom prevalence and specificity of porphyrin precursors in carriers of acute hepatic porphyria","volume":"45","author":"Merati","year":"2025","journal-title":"Liver Int."},{"key":"10.1016\/j.ymgme.2026.110263_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15894","article-title":"Liver transplantation and primary liver cancer in porphyria","volume":"45","author":"Lissing","year":"2025","journal-title":"Liver Int."},{"key":"10.1016\/j.ymgme.2026.110263_bb0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/cei.12899","article-title":"Systemic inflammation in acute intermittent porphyria: a case-control study","volume":"187","author":"Storjord","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110263_bb0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2019.05.010","article-title":"Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias","volume":"128","author":"Dixon","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110263_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: a revolutionary tool for transcriptomics","volume":"10","author":"Wang","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymgme.2026.110263_bb0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/intimm\/dxh246","article-title":"Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells","volume":"17","author":"van Vliet","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ymgme.2026.110263_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00305","article-title":"Activation of the C-type lectin MGL by terminal GalNAc ligands reduces the glycolytic activity of human dendritic cells","volume":"11","author":"Zaal","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymgme.2026.110263_bb0090","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.immuni.2024.03.005","article-title":"Myeloid C-type lectin receptors in innate immune recognition","volume":"57","author":"Reis e Sousa","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.ymgme.2026.110263_bb0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2340\/00015555-0178","article-title":"Safe usage of isotretinoin in a woman with latent acute intermittent porphyria","volume":"87","author":"Storjord","year":"2007","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ymgme.2026.110263_bb0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/0003-4819-144-7-200604040-00023","article-title":"Reconstitution of hematin for intravenous infusion","volume":"144","author":"Anderson","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2026.110263_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00744","article-title":"CLEC10A is a specific marker for human CD1c(+) dendritic cells and enhances their Toll-like receptor 7\/8-induced cytokine secretion","volume":"9","author":"Heger","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymgme.2026.110263_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13072","article-title":"The C-type lectin receptor MGL senses N-acetylgalactosamine on the unique Staphylococcus aureus ST395 wall teichoic acid","volume":"21","author":"Mnich","year":"2019","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ymgme.2026.110263_bb0115","first-page":"2235","article-title":"Update on heme biosynthesis, tissue-specific regulation, heme transport, relation to iron metabolism and cellular energy","volume":"44","author":"Belot","year":"2024","journal-title":"Liver Int. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.ymgme.2026.110263_bb0120","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110263_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hep4.1297","article-title":"Acute hepatic porphyrias: review and recent progress","volume":"3","author":"Wang","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ymgme.2026.110263_bb0130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.gastro.2022.11.034","article-title":"AGA clinical practice update on diagnosis and management of acute hepatic porphyrias: expert review","volume":"164","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymgme.2026.110263_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/j.gastro.2019.04.050","article-title":"Clinical guide and update on porphyrias","volume":"157","author":"Stolzel","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymgme.2026.110263_bb0140","first-page":"1","article-title":"Benefits of prophylactic heme therapy in severe acute intermittent porphyria","volume":"19","author":"Yarra","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110263_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.712305","article-title":"Prophylactic heme arginate infusion for acute intermittent porphyria","volume":"12","author":"Kuo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymgme.2026.110263_bb0150","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000327","article-title":"Long-term management and treatment of acute intermittent porphyria with recurring attacks using pharmacological prophylaxis","volume":"7","author":"Kuo","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ymgme.2026.110263_bb0155","series-title":"International Porphyrias Symposium 2025, Arlington, VA","article-title":"A double-blind placebo controlled pilot study of intravenous hemin for prevention of frequent acute attacks of acute hepatic porphyria","author":"Moghe","year":"2025"},{"key":"10.1016\/j.ymgme.2026.110263_bb0160","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3748\/wjg.v19.i10.1593","article-title":"Heme status affects human hepatic messenger RNA and microRNA expression","volume":"19","author":"Bonkovsky","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymgme.2026.110263_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2025.1543455","article-title":"Major heme proteins hemoglobin and myoglobin with respect to their roles in oxidative stress - a brief review","volume":"13","author":"Sil","year":"2025","journal-title":"Front. Chem."},{"key":"10.1016\/j.ymgme.2026.110263_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/290708","article-title":"Induction of heme oxygenase-1 with hemin reduces obesity-induced adipose tissue inflammation via adipose macrophage phenotype switching","volume":"2014","author":"Tu","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ymgme.2026.110263_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2014.04.043","article-title":"Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man","volume":"158","author":"Jais","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2026.110263_bb0180","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1476-5381.2010.00990.x","article-title":"Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects","volume":"161","author":"Doberer","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2026.110263_bb0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/joim.12750","article-title":"Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver","volume":"284","author":"Schmitt","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2026.110263_bb0190","article-title":"Mechanisms of neuronal damage in acute hepatic porphyrias","volume":"11","author":"Ricci","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ymgme.2026.110263_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2026.110263_bb0200","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymgme.2026.110263_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144818","article-title":"ASGR1 and its enigmatic relative, CLEC10A","volume":"21","author":"Hoober","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110263_bb0210","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","article-title":"Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug","volume":"28","author":"Debacker","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110263_bb0215","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/hmg\/ddw013","article-title":"Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency","volume":"25","author":"Collantes","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2026.110263_bb0220","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cell.2005.06.040","article-title":"Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha","volume":"122","author":"Handschin","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2026.110263_bb0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0026-0495(64)90103-9","article-title":"Factors affecting the excretion of porphyrin precursors by patients with acute intermittent porphyria. I. The effect of diet","volume":"13","author":"Welland","year":"1964","journal-title":"Metabolism"},{"key":"10.1016\/j.ymgme.2026.110263_bb0230","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/BF01721260","article-title":"The \u201cglucose effect\u201d in acute hepatic porphyrias and in experimental porphyria","volume":"59","author":"Doss","year":"1981","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.ymgme.2026.110263_bb0235","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/diacare.25.4.797","article-title":"Beneficial effect of diabetes on acute intermittent porphyria","volume":"25","author":"Lithner","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymgme.2026.110263_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12809","article-title":"Nontargeted urine metabolomic analysis of acute intermittent porphyria reveals novel interactions between bile acids and heme metabolism: new promising biomarkers for the long-term management of patients","volume":"48","author":"Lefebvre","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110263_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063219","article-title":"Evaluation of metabolic changes in acute intermittent porphyria patients by targeted metabolomics","volume":"23","author":"Gomez-Gomez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110263_bb0250","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2017.05.014","article-title":"Effect of the anticoagulant, storage time and temperature of blood samples on the concentrations of 27 multiplex assayed cytokines - consequences for defining reference values in healthy humans","volume":"97","author":"Henno","year":"2017","journal-title":"Cytokine"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:32:04Z","timestamp":1794252724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226005469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1096719226005469"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110263","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-type lectin 10A [CD301] mRNA is upregulated in symptomatic acute intermittent porphyria and decreases after heme treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110263"}}